THE CYTOPLASMIC PEPTIDOGLYCAN PRECURSOR OF VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECALIS TERMINATES IN LACTATE

被引:81
|
作者
HANDWERGER, S
PUCCI, MJ
VOLK, KJ
LIU, JP
LEE, MS
机构
[1] BRISTOL MYERS SQUIBB CO,ANTIINFECT MICROBIOL,WALLINGFORD,CT 06492
[2] BRISTOL MYERS SQUIBB CO,ANALYT RES,WALLINGFORD,CT 06492
关键词
D O I
10.1128/jb.174.18.5982-5984.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Vancomycin resistance plasmids in enterococci carry the genes vanH and vanA, which encode enzymes catalyzing, respectively, the reduction of 2-keto acids to 2-D-hydroxy acids and the addition Of D-hydroxy acids to D-alanine. It has therefore been postulated that resistant cells produce peptidoglycan precursors that terminate in the depsipeptide D-alanine-2-D-hydroxy acid rather than the dipeptide D-alanine-D-alanine, thus preventing vancomycin binding (M. Arthur, C. Molinas, T. D. H. Bugg, G. D. Wright, C. T. Walsh, and P. Courvalin, Antimicrob. Agents Chemother. 36:867-869, 1992). In the present work, a cytoplasmic peptidoglycan precursor was isolated from vancomycin-resistant Enterococcus faecalis and analyzed by mass spectrometry, which suggested the structure UDP-N-acetyl-muramyl-L-Ala-D-Glu-L-LyS-D-Ala-D-lactate.
引用
收藏
页码:5982 / 5984
页数:3
相关论文
共 50 条
  • [1] INVITRO SUSCEPTIBILITY STUDIES OF VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECALIS
    SAHM, DF
    KISSINGER, J
    GILMORE, MS
    MURRAY, PR
    MULDER, R
    SOLLIDAY, J
    CLARKE, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) : 1588 - 1591
  • [2] VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECALIS - NOW ALSO IN BELGIUM
    COENE, J
    DEBRAUWER, E
    GORDTS, B
    VANLANDUYT, H
    ACTA CLINICA BELGICA, 1995, 50 (01): : 46 - 47
  • [3] VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECALIS PERITONITIS IN A CAPD PATIENT
    EJAZ, AA
    PINORIS, A
    TIWARI, P
    DISILVESTRO, V
    ZABANEH, RI
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 527 - 527
  • [4] Altered peptidoglycan composition in vancomycin-resistant Enterococcus faecalis
    DeJonge, BLM
    Handwerger, S
    Gage, D
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) : 863 - 869
  • [5] Vancomycin-resistant Enterococcus faecalis
    Branley, J
    Yan, B
    Benn, RAV
    MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (05) : 292 - 292
  • [6] Vancomycin-resistant Enterococcus faecalis in Serbia
    Stosovic, B
    Stepanovic, S
    Donabedian, S
    Tosic, T
    Jovanovic, M
    EMERGING INFECTIOUS DISEASES, 2004, 10 (01) : 157 - 158
  • [7] Peptidoglycan O-acetylation increases in response to vancomycin treatment in vancomycin-resistant Enterococcus faecalis
    Chang, James D.
    Foster, Erin E.
    Wallace, Ashley G.
    Kim, Sung Joon
    SCIENTIFIC REPORTS, 2017, 7
  • [8] Peptidoglycan O-acetylation increases in response to vancomycin treatment in vancomycin-resistant Enterococcus faecalis
    James D. Chang
    Erin E. Foster
    Ashley G. Wallace
    Sung Joon Kim
    Scientific Reports, 7
  • [9] Peptidoglycan composition of vancomycin-resistant Enterococcus faecium
    deJonge, BLM
    Gage, D
    Handwerger, S
    MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1996, 2 (02): : 225 - 229
  • [10] Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis
    Oprea, SF
    Zaidi, N
    Donabedian, SM
    Balasubramaniam, M
    Hershberger, E
    Zervos, MJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (04) : 626 - 630